Kalvista Pharmaceuticals Inc (KALV) — Cash Flow Reinvestment Rate

Latest as of January 2018: 0.01x

Kalvista Pharmaceuticals Inc (KALV) has a Cash Flow Reinvestment Rate of 0.01x as of January 2018, reinvesting $182.00K (capex $182.00K ) from operating cash flow of $28.22 Million. Explore Kalvista Pharmaceuticals Inc (KALV) cash flow conversion to assess how effectively this company generates cash.

Reinvestment Rate

0.01x
(Capex + Investments) / Operating CF

Total Reinvested

$182.00K
Capex + Investments

Operating Cash Flow

$28.22 Million
USD

Capital Expenditures

$182.00K
USD

Kalvista Pharmaceuticals Inc Cash Flow Reinvestment Rate (2018–2018)

Historical reinvestment intensity for Kalvista Pharmaceuticals Inc across 1 annual periods. Explore Kalvista Pharmaceuticals Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Kalvista Pharmaceuticals Inc (2018–2018)

Year-by-year capital reinvestment analysis for Kalvista Pharmaceuticals Inc. For live market cap and broader valuation context, see Kalvista Pharmaceuticals Inc stock valuation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2018 0.27x $2.85 Million $10.56 Million $1.43 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow